ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies
ASCO Updates Guideline On Antiemetics
New Drug Combination Shrinks Kidney Cancers
Docetaxel, Oxaliplatin Active Against Esophageal Cancer
BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery
Communication Is Key To Clinical Trial Enrollment
FDA Approves Treatment For Late-Stage Cervical Cancer
NCI-Approved Clinical Trials
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









